Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Promino Nutritional Sciences Inc (MUSL)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
0.16 0.00    0.00%
26/04 - Closed. Currency in CAD ( Disclaimer )
Type:  Equity
Market:  Canada
  • Volume: 572,002
  • Bid/Ask: 0.16 / 0.17
  • Day's Range: 0.16 - 0.18
Promino Nutritional Sciences 0.16 0.00 0.00%

MUSL Recent Sentiments

 
This page contains information on users’ sentiments for the Promino Nutritional Sciences Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 16, 2024 Andreas Haase   0.17 -5.88%
Apr 01, 2024 Mike Em   0.24 Apr 08, 2024 @ 0.19 -20.83%
Feb 08, 2024 Dawson Moses   0.10 Mar 01, 2024 @ 0.08 -20.00%
Jun 13, 2022 Saud alkahathalan   0.23 Jul 08, 2022 @ 0.17 +26.09%
Feb 15, 2022 Peter Kriel   0.32 Feb 21, 2022 @ 0.31 -3.13%
Jul 28, 2021 Kim Shaheen   0.70 Aug 02, 2021 @ 0.67 -4.29%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

MUSL Comments

Write your thoughts about Promino Nutritional Sciences Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mike Powell
Mike Powell Jun 08, 2022 12:11PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Stock values for Element Nutritional Sciences have gone up 100% since mid-May lows. This is in credit to the company’s strong reported Q1 results demonstrating significant revenue growth (+559% YoY), wide distribution networks (16k+) and more news including a 2-year exclusive agreement with Dr. James LaVelle representing their patented portfolio of products. Definitely tune into Equity Guru’s Investor Roundtable where $ELMT is in focus. Search the video on YouTube titled: Element Nutritional Sciences (ELMT.C) - Investor Roundtable Video #4
Reply
1 0
Report
Mike Powell
Mike Powell Jun 06, 2022 1:35PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
News if you missed it at original publishing - Element Nutritional Sciences has signed Dr. James LaValle to an exclusive two-year agreement to represent their patented product portfolio including Rejuvenate and Promino. Dr. LaValle is a clinical pharmacist and board-certified clinical nutritionist.
Reply
0 0
Report
Mike Powell
Mike Powell Jun 02, 2022 2:49PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Award winning clinical pharmacist and board-certified clinical nutritionist with 35+ years experience practicing wellness, prevention and disease state management, Dr. James LaVelle has signed an exclusive 2-year agreement to represent Elemental Nutrition sciences’ patented Rejuvenate and Promino products. This agreement will see Dr. LaValle appearing on TV and digital campaigns to highlight Element’s unique IP-driven products.
Reply
0 0
Report
Jeremy Lin
Jeremy Lin Jun 01, 2022 2:14PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Probably among some of the best results that I've seen from a company this Q. 559% YoY revenue growth with a gross margin of 40%. Plus, sales are only set to grow further as they continue to expand the distribution network and innovate new products (completed production trials for its new Rejuvenate Muscle Activator product for release by Q3). Looking good here.
Reply
0 0
Report
Mike Powell
Mike Powell May 31, 2022 1:06PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Element releases their Q1 F'22 results - “We started the year with a milestone quarter highlighted by record revenues of $2.3 million, demonstrating a year-over-year growth of 559%.” With a focused pipeline on further expanded distribution and product launches, the future looks high potential for Element.
Reply
0 0
Report
Mike Powell
Mike Powell May 26, 2022 2:05PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
ICYMI Aaron from Departures Capital gives a solid breakdown on what to expect from Element Nutritional Sciences. Following the anticipated release of record revenues from Q1 F’22 they are expected to report $2-2.3M in revenues representing a 521% YoY increase. I’m particularly looking forward to how they’ll grow their already impressive distribution at 16k+ retail points throughout this year. ETA for complete results by end of this month. Find the video on YouTube titled: Element Nutritional Sciences to Report Record Revenue in Q1 2022 (CSE:ELMT) (OTC:ELNSF)
Reply
0 0
Report
Mike Powell
Mike Powell May 24, 2022 1:32PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Final Q1 results from $ELMT expected before May ends. Preliminary results are painting a solid success story raking in $2-2.3M with an estimated 521% YoY increase at the mid-range from 35-40% gross margins. Market’s certainly reflected that with last week’s green.
Reply
0 0
Report
Mike Powell
Mike Powell May 18, 2022 12:48PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Passing the $3M mark a couple weeks ago, Stuart Lowther comments: “Our sales last year were $2.5M for the entire year. So our YoY quarter increase is ~467% over last year. That’s a big growth number we like, but it shows we’re heading in the right direction.” On target $10M run rate. Check out this YouTube video on the Jay Martin Show titled: Massive Growth for Element Nutritional Sciences - ELMT
Reply
0 0
Report
Mike Powell
Mike Powell May 16, 2022 1:22PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Preliminary Q1-22 results indicate that Element Nutritional Sciences is expecting to report milestone revenues at $2-2.3M, a 521%+ YoY increase - attributed in part to their impressive distribution channels reaching 16k+ in North America.
Reply
0 0
Report
Mike Powell
Mike Powell May 12, 2022 12:41PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Element Nutritional Sciences has a stacked portfolio of patented products that are clinically superior to competitors, massive distribution, and are consistently rated more effective and palpable by customers. This is a solid time to jump in, at discounts of $0.18/share - following this recent $3.5M financing it’s expected to see some upward movement.
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email